Transcriptional induction of the p69 isoform of 2',5'-oligoadenylate synthetase by interferon-β and interferon-γ involves three regulatory elements and interferon-stimulated gene factor 3

Experimental Cell Research

Volumn 246, Issue 1, 1999, Pages 138-147

  Floyd Smith, Georgia ^a,b   Wang, Qing ^a   Sen, Ganes C ^b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Antiviral; Glioma; IRF 1; ISRE; Luciferase; STAT1

Indexed keywords

2',5' OLIGOADENYLATE SYNTHASE; BETA INTERFERON; GAMMA INTERFERON; INTERFERON STIMULATED GENE FACTOR 3; LUCIFERASE; PROTEIN P40; PROTEIN P69; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0033540288     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4296     Document Type: Article

References (52)

1. Lengyel P. Biochemistry of interferons and their actions. Annu. Rev. Biochem. 51:1982;251-282.
2. Sen G. C., Lengyel P. The interferon system: A bird's eye view of its biochemistry. J. Biol. Chem. 267:1992;5017-5020.
3. Kerr I. M., Brown R. E. pppA2′p5′A2′p5′A: An inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA. 75:1978;256-260.
4. Floyd-Smith G., Slattery E., Lengyel P. Interferon action: RNA cleavage pattern of a (2′,5′) oligoadenylate-dependent endonuclease. Science. 212:1981;1030-1032.
5. Rice A. P., Duncan R., Hershey J. W. B., Kerr I. M. Double-stranded RNA-dependent protein kinase and 2-5A system are both activated in interferon-treated, encephalomyocarditis virus-infected HeLa cells. J. Virol. 54:1985;894-898.
6. Chebath J., Benech P., Revel M., Vigneron M. Constitutive expression of (2′-5′)oligo A synthetase confers resistance to picornavirus infection. Nature. 330:1987;587-588.
7. Kumar R., Choubey D., Lengyel P., Sen G. C. Studies on the role of the 2′-5′-oligoadenylate synthetase-RNase l pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication. J. Virol. 62:1988;3175-3181.
8. Diaz-Guerra M., Rivas C., Esteban M. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology. 227:1997a;220-228.
9. Lengyel P. Tumor-suppressor gene: news about the interferon connection. Proc. Natl. Acad. Sci. USA. 90:1993;5893-5895.
10. Salzberg S., Hyman T., Turm H., Kinar Y., Schwartz Y., Nir U., Lejbkowicz F., Huberman E. Ectopic expression of 2-5A synthetase in myeloid cells induces growth arrest and facilitates the appearance of a myeloid differentiation marker. Cancer Res. 57:1997;2732-2740.
11. Diaz-Guerra M., Rivas C., Esteban M. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology. 236:1997b;354-363.
12. Chebath J., Benech P., Hovanessian A. G., Galabru J., Revel M. Four different forms of interferon-induced 2′-5′-oligo(A) synthetase identified by immunoblotting in human cells. J. Biol. Chem. 262:1987;3852-3857.
13. Benech P., Mory Y., Revel M., Chebath J. Structure of two forms of the interferon-induced (2′-5′) oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J. 4:1985;2249-2256.
14. Marié I., Hovanessian A. G. The 69-kDa 2-5A synthetase is composed of two homologous and adjacent functional domains. J. Biol. Chem. 267:1992;9933-9939.
15. Hovanessian A. G. Interferon-induced and double-stranded RNA-activated enzymes: A specific protein kinase and 2′-5′-oligoadenylate synthetases. J. Interferon Res. 11:1991;199-205.
16. Marié I., Blanco J., Rebouillat D., Hovanessian A. G. 69-kDa and 100-kDa isoforms of interferon-induced (2′-5′)oligoadenylate synthetase exhibit differential catalytic parameters. Eur. J. Biochem. 248:1997;558-566.
17. Bandyopadhyay S., Ghosh A., Sarkar S. N., Sen G. C. Production and purification of recombinant 2′5′ oligoadenylate synthetase and its mutants using the Baculovirus system. Biochemistry. 37:1998;3824-3830.
18. Marié I., Svab J., Robert N., Galabru J., Hovanessian A. G. Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A synthetase in human cells treated with interferon. J. Biol. Chem. 265:1990;18601-18607.
19. Yu F., Floyd-Smith G. Protein kinase C is required for induction of 2′,5′-oligoadenylate synthetases. Exp. Cell Res. 234:1997;240-248.
20. Witt P. l., Marie I., Robert N., Irizarry A., Borden E. C., Hovanessian A. G. Isoforms p69 and p100 of 2′,5′-oligoadenylate synthetase induced differentially by interferons in vivo and in vitro. J. Interferon Res. 13:1993;17-23.
21. Kumar R., Korutla L., Zhang K. Cell cycle-dependent modulation of α-interferon-inducible gene expression and activationof. J. Biol. Chem. 269:1994;25437-25441.
22. Schindler C., Darnell J. E. Jr. Transcriptional responses to polypeptide ligands: The JAK-STAT Pathway. Annu. Rev. Biochem. 64:1995;621-651.
23. Darnell J. E., Kerr I. M., Stark G. R. Jak-STAT pathways to IFNs and other signaling proteins. Science. 264:1994;1415-1421.
24. Wang Q., Floyd-Smith G. The p69/71 2-5A synthetase promoter contains multiple regulatory elements required for interferon-α-induced expression. DNA Cell Biol. 16:1997;1385-1394.
25. Benech P., Vigneron M., Peretz D., Revel M., Chebath J. Interferon-responsive regulatory elements in the promoter of the human 2′,5′-oligo(A) synthetase gene. Mol. Cell. Biol. 7:1987;4498-4504.
26. Pellegrini S., John J., Shearer M., Kerr I. M., Stark G. R. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9:1989;4605-4612.
27. Li X., Leung S., Quresh S., Darnell J. E. Jr., Stark G. R. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-α J. Biol. Chem. 271:1996;5790-5794.
28. Müller M., Laxton C., Briscoe J., Schindler C., Improta T., Darnell J. E. Jr., Stark G. R., Kerr I. M. Complementation of a mutant cell line: Central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J. 12:1993;4221-4228.
29. Leung S., Qureshi S. A., Kerr I. M., Darnell J. E. Jr., Stark G. R. Role of STAT2 in the alpha interferon signaling pathway. Mol. Cell. Biol. 15:1995;1312-1317.
30. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
31. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 1639.
32. Ghosh S. K., Kusari J., Bandyopadhyay S. K., Samanta H., Kumar R., Sen G. C. Cloning, sequencing, and expression of two murine 2′-5′-oligoadenylate synthetases: Structure-function relationships. J. Biol. Chem. 266:1991;15293-15299.
33. Shiojiri S., Fukunaga R., Ichii Y., Sokawa Y. Structure and expression of a cloned cDNA for human (2′-5′)oligoadenylate synthetase. J. Biochem. 99:1986;1455-1464.
34. Enoch T., Zinn K., Maniatis T. Activation of the human βinterferon gene requires an interferoninducible factor. Mol. Cell. Biol. 6:1986;801-810.
35. Tanaka N., Kawakami T., Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13:1993;4531-4538.
36. Wasylyk B., Wasylyk C., Flores P., Begue A., Leprince D., Stehelin D. The c-ets. Nature. 346:1990;191-193.
37. Angel P., Imagawa M., Chiu R., Stein B., Imbra R. J., Rahmsdorf H. J., Jonat C., Herlich P., Karin M. Phorbol ester-inducible genes contain a commoncistrans. Cell. 49:1987;729-739.
38. Lee W., Haslinger A., Karin M., Tjian R. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene ad SV40. Nature. 325:1987;368-372.
39. Poli V., Mancini F. P., Cortese R. IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell. 63:1990;643-653.
40. Thanos D., Maniatis T. NF-κB: A lesson in family values. Cell. 80:1995;529-532.
41. McMahon M., Stark G. R., Kerr I. M. Interferon-induced gene expression in wild-type and interferon-resistant human lymphoblastoid (Daudi) cells. J. Virol. 57:1986;362-366.
42. Matsuyama T., Kimura T., Kitagawa M., Pfeffer K., Kawakami T., Watanabe N., Kundig T. M., Amakawa R., Kishihara K., Wakeham A., Potter J., Furlonger C. L., Narendran A., Suzuki H., Ohashi P. S., Paige C. J., Taniguchi T., Mak T. W. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 75:1993;83-97.
43. Kimura T., Nakayama K., Penninger J., Kitagawa M., Harada H., Matsuyama T., Tanaka N., Kamijo R., Vilcek J., Mak T. W., Taniguchi T. Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science. 264:1994;1921-1924.
44. Eisenbeis C. F., Singh H., Storb U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9:1995;1377-1387.
45. Driggers P. H., Ennist D. L., Gleason S. L., Mak W.-H., Marks M. S., Levi B.-Z., Flanagan J. R., Appella E., Ozato K. An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA. 87:1990;3743-3747.
46. Damore M. A., Omori S. A., Wall R. IFN-γ induces the κ intron enhancer via an IFN-stimulated response element. J. Immunol. 156:1996;2451-2457.
47. Levy D., Kessler D., Pine R., Reich N., Darnell J. E. Jr. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev. 2:1988;383-393.
48. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., Taniguchi T. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell. 58:1989;729-739.
49. Smale S. T., Baltimore D. The "initiator" as a transcription control element. Cell. 57:1989;103-113.
50. Konan K. V., Taylor M. W. Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene. J. Biol. Chem. 271:1996;19140-19145.
51. Kao W. Y., Dworkin L. L., Briggs J. A., Briggs R. C. Characterization of the human myeloid cell nuclear differentiation antigen gene promoter. Biochim. Biophys. Acta. 1308:1996;201-204.
52. Tanaka N., Ishihara M., Lamphier M. S., Nozawa H., Matsuyama T., Mak T. W., Aizawa S., Tokino T., Oren M., Taniguchi T. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature. 382:1996;816-818.